Cargando…

Immunohistochemical Analysis of Prurigo Nodularis in 209 Patients: Clinicopathological Analysis between Atopic and Non-Atopic Patients and between Treatment Response Groups

BACKGROUND: Prurigo nodularis (PN) is a highly pruritic disease that significantly impairs patient quality of life. Although the mechanism that causes pruritus is not clear, one hypothesis argues that neural hyperplasia, mast cell, and Merkel cell neurite complexes may be associated with PN pathogen...

Descripción completa

Detalles Bibliográficos
Autores principales: Byun, Hyun Jeong, Jang, Donghwi, Lee, Dong-Youn, Yang, Jun-Mo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Dermatological Association; The Korean Society for Investigative Dermatology 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8273323/
https://www.ncbi.nlm.nih.gov/pubmed/34341634
http://dx.doi.org/10.5021/ad.2021.33.4.333
_version_ 1783721344879296512
author Byun, Hyun Jeong
Jang, Donghwi
Lee, Dong-Youn
Yang, Jun-Mo
author_facet Byun, Hyun Jeong
Jang, Donghwi
Lee, Dong-Youn
Yang, Jun-Mo
author_sort Byun, Hyun Jeong
collection PubMed
description BACKGROUND: Prurigo nodularis (PN) is a highly pruritic disease that significantly impairs patient quality of life. Although the mechanism that causes pruritus is not clear, one hypothesis argues that neural hyperplasia, mast cell, and Merkel cell neurite complexes may be associated with PN pathogenesis. OBJECTIVE: The objective of this study was to analyze whether special staining outcomes differed depending on the presence of atopic dermatitis (AD) and treatment response. METHODS: A total of 209 patients diagnosed with PN was analyzed retrospectively. Patients were divided into two groups according to presence or past history of AD and by treatment response. Histopathologic features were obtained using the following stains: Giemsa, S-100, neuron-specific enolase, cytokeratin (CK)-20, CAM5.2, and CK8/CK18. RESULTS: A total of 126 patients (60.29%) had AD, and 68 (32.54%) showed clinical improvement. There were no statistically significant differences in the staining results between the PN groups with AD (PN c AD) and without AD (PN s AD). Additionally, there were no statistically significant differences in staining results between the improved and non-improved groups. CONCLUSION: Implementing the special stains helped to identify PN pathogenesis. Because there were no statistically significant differences in the special stain results between the improved and non-improved groups, we conclude that mast cell proliferation, neural hyperplasia, and Merkel cell hyperplasia may not have a significant effect on treatment response.
format Online
Article
Text
id pubmed-8273323
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher The Korean Dermatological Association; The Korean Society for Investigative Dermatology
record_format MEDLINE/PubMed
spelling pubmed-82733232021-08-01 Immunohistochemical Analysis of Prurigo Nodularis in 209 Patients: Clinicopathological Analysis between Atopic and Non-Atopic Patients and between Treatment Response Groups Byun, Hyun Jeong Jang, Donghwi Lee, Dong-Youn Yang, Jun-Mo Ann Dermatol Original Article BACKGROUND: Prurigo nodularis (PN) is a highly pruritic disease that significantly impairs patient quality of life. Although the mechanism that causes pruritus is not clear, one hypothesis argues that neural hyperplasia, mast cell, and Merkel cell neurite complexes may be associated with PN pathogenesis. OBJECTIVE: The objective of this study was to analyze whether special staining outcomes differed depending on the presence of atopic dermatitis (AD) and treatment response. METHODS: A total of 209 patients diagnosed with PN was analyzed retrospectively. Patients were divided into two groups according to presence or past history of AD and by treatment response. Histopathologic features were obtained using the following stains: Giemsa, S-100, neuron-specific enolase, cytokeratin (CK)-20, CAM5.2, and CK8/CK18. RESULTS: A total of 126 patients (60.29%) had AD, and 68 (32.54%) showed clinical improvement. There were no statistically significant differences in the staining results between the PN groups with AD (PN c AD) and without AD (PN s AD). Additionally, there were no statistically significant differences in staining results between the improved and non-improved groups. CONCLUSION: Implementing the special stains helped to identify PN pathogenesis. Because there were no statistically significant differences in the special stain results between the improved and non-improved groups, we conclude that mast cell proliferation, neural hyperplasia, and Merkel cell hyperplasia may not have a significant effect on treatment response. The Korean Dermatological Association; The Korean Society for Investigative Dermatology 2021-08 2021-07-01 /pmc/articles/PMC8273323/ /pubmed/34341634 http://dx.doi.org/10.5021/ad.2021.33.4.333 Text en Copyright © 2021 The Korean Dermatological Association and The Korean Society for Investigative Dermatology https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0 (https://creativecommons.org/licenses/by-nc/4.0/) ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Byun, Hyun Jeong
Jang, Donghwi
Lee, Dong-Youn
Yang, Jun-Mo
Immunohistochemical Analysis of Prurigo Nodularis in 209 Patients: Clinicopathological Analysis between Atopic and Non-Atopic Patients and between Treatment Response Groups
title Immunohistochemical Analysis of Prurigo Nodularis in 209 Patients: Clinicopathological Analysis between Atopic and Non-Atopic Patients and between Treatment Response Groups
title_full Immunohistochemical Analysis of Prurigo Nodularis in 209 Patients: Clinicopathological Analysis between Atopic and Non-Atopic Patients and between Treatment Response Groups
title_fullStr Immunohistochemical Analysis of Prurigo Nodularis in 209 Patients: Clinicopathological Analysis between Atopic and Non-Atopic Patients and between Treatment Response Groups
title_full_unstemmed Immunohistochemical Analysis of Prurigo Nodularis in 209 Patients: Clinicopathological Analysis between Atopic and Non-Atopic Patients and between Treatment Response Groups
title_short Immunohistochemical Analysis of Prurigo Nodularis in 209 Patients: Clinicopathological Analysis between Atopic and Non-Atopic Patients and between Treatment Response Groups
title_sort immunohistochemical analysis of prurigo nodularis in 209 patients: clinicopathological analysis between atopic and non-atopic patients and between treatment response groups
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8273323/
https://www.ncbi.nlm.nih.gov/pubmed/34341634
http://dx.doi.org/10.5021/ad.2021.33.4.333
work_keys_str_mv AT byunhyunjeong immunohistochemicalanalysisofprurigonodularisin209patientsclinicopathologicalanalysisbetweenatopicandnonatopicpatientsandbetweentreatmentresponsegroups
AT jangdonghwi immunohistochemicalanalysisofprurigonodularisin209patientsclinicopathologicalanalysisbetweenatopicandnonatopicpatientsandbetweentreatmentresponsegroups
AT leedongyoun immunohistochemicalanalysisofprurigonodularisin209patientsclinicopathologicalanalysisbetweenatopicandnonatopicpatientsandbetweentreatmentresponsegroups
AT yangjunmo immunohistochemicalanalysisofprurigonodularisin209patientsclinicopathologicalanalysisbetweenatopicandnonatopicpatientsandbetweentreatmentresponsegroups